{"transactions":[{"id":744244,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":72000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":744243,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":33000,"price":240.09,"value":7922970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.46 and $242.35."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":42867,"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":744242,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":true,"shares":33000,"price":3.5,"value":115500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for over 8 years and exercised prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":75867,"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":801684,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:00:44.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":8188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":8188,"derivative":{"underlying":"Common Stock","underlying_shares":8188},"source":{"system":"sec-edgar","filing":"0001193125-26-174412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526174412/ownership.xml","form_type":"4"}},{"id":876635,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:07.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":18570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":18570,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":18570},"source":{"system":"sec-edgar","filing":"0001193125-26-083608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526083608/ownership.xml","form_type":"4"}},{"id":932009,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":105000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":932008,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":187.92,"value":2255040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $185.09 and $191.12."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":42588,"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":932007,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":3.5,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 8 years and exercised prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":54588,"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":1245274,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2025-02-26T00:54:49.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":9423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each PSU will vest upon achievement of certain financial, regulatory and developmental performance milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each PSU will vest upon achievement of certain financial, regulatory and developmental performance milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":9423,"derivative":{"underlying":"Common Stock","underlying_shares":9423},"source":{"system":"sec-edgar","filing":"0000950170-25-027070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025027070/ownership.xml","form_type":"4"}},{"id":1245273,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-26T00:54:49.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":9423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 21, 2029. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 21, 2029. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":9423,"derivative":{"underlying":"Common Stock","underlying_shares":9423},"source":{"system":"sec-edgar","filing":"0000950170-25-027070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025027070/ownership.xml","form_type":"4"}},{"id":1245272,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-26T00:54:49.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":9516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on February 21, 2029."}],"balance_after":9516,"derivative":{"exercise_price":137.75,"expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":9516},"source":{"system":"sec-edgar","filing":"0000950170-25-027070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025027070/ownership.xml","form_type":"4"}},{"id":1266686,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":3.5,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":0,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1266685,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":3.5,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":0,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1266684,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":131.07,"value":393210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $130.06 and $131.72."}],"balance_after":42187,"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1266683,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":3.5,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":45187,"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1266682,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":129.86,"value":1558320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $128.50 and $131.64."}],"balance_after":42187,"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1266681,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-15T02:20:36.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":3.5,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed."}],"balance_after":54187,"source":{"system":"sec-edgar","filing":"0000950170-25-021716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025021716/ownership.xml","form_type":"4"}},{"id":1609472,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T23:25:17.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":15774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on February 27, 2028.  Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on February 27, 2028.  Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":15774,"derivative":{"underlying":"Common Stock","underlying_shares":15774},"source":{"system":"sec-edgar","filing":"0000950170-24-023364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024023364/ownership.xml","form_type":"4"}},{"id":1609471,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-29T23:25:17.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":28722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on February 27, 2028."}],"balance_after":28722,"derivative":{"exercise_price":84,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":28722},"source":{"system":"sec-edgar","filing":"0000950170-24-023364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024023364/ownership.xml","form_type":"4"}},{"id":1968260,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-03-06T23:14:52.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":20554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 2, 2027. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 2, 2027. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":20554,"derivative":{"underlying":"Common Stock","underlying_shares":20554},"source":{"system":"sec-edgar","filing":"0001209191-23-016457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919123016457/doc4.xml","form_type":"4"}},{"id":1968259,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-06T23:14:52.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":36246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 2, 2027."}],"balance_after":36246,"derivative":{"exercise_price":65.32,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":36246},"source":{"system":"sec-edgar","filing":"0001209191-23-016457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919123016457/doc4.xml","form_type":"4"}},{"id":2343752,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2022-03-08T22:02:27.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":41176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 4, 2026. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 4, 2026. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":41176,"derivative":{"underlying":"Common Stock","underlying_shares":41176},"source":{"system":"sec-edgar","filing":"0001209191-22-017158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919122017158/doc4.xml","form_type":"4"}},{"id":2343751,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-08T22:02:27.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":77872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 4, 2026."}],"balance_after":77872,"derivative":{"exercise_price":29.91,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":77872},"source":{"system":"sec-edgar","filing":"0001209191-22-017158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919122017158/doc4.xml","form_type":"4"}},{"id":2500084,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T12:31:17.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":142,"price":35.2,"value":4998.4,"ownership":{"direct":false,"nature":"By UTMA account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 142 shares of common stock indirectly held by the reporting person as custodian for his other son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":142,"source":{"system":"sec-edgar","filing":"0001209191-21-066005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919121066005/doc4.xml","form_type":"4"}},{"id":2500083,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T12:31:17.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":145,"price":34.3,"value":4973.5,"ownership":{"direct":false,"nature":"By UTMA account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 145 shares of common stock indirectly held by the reporting person as custodian for his daughter's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":145,"source":{"system":"sec-edgar","filing":"0001209191-21-066005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919121066005/doc4.xml","form_type":"4"}},{"id":2500082,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T12:31:17.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":141,"price":35.43,"value":4995.63,"ownership":{"direct":false,"nature":"By UTMA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.42 to $35.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 141 shares of common stock indirectly held by the reporting person as custodian for his son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other 4."}],"balance_after":201,"source":{"system":"sec-edgar","filing":"0001209191-21-066005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919121066005/doc4.xml","form_type":"4"}},{"id":2500081,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T12:31:17.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":527,"price":35.5,"value":18708.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.39 to $35.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":41789,"source":{"system":"sec-edgar","filing":"0001209191-21-066005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919121066005/doc4.xml","form_type":"4"}},{"id":2512313,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-16T00:55:09.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":36086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will start to vest one year from November 12, 2021 and then will vest in substantially equal quarterly installments over three years such that the option will be fully vested on November 12, 2025."}],"balance_after":36086,"derivative":{"exercise_price":39.26,"expiration_date":"2031-11-11","underlying":"Common Stock","underlying_shares":36086},"source":{"system":"sec-edgar","filing":"0001209191-21-064589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000120919121064589/doc4.xml","form_type":"4"}},{"id":2798938,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-10T02:48:54.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":19208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 5, 2025. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 5, 2025. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":19208,"derivative":{"underlying":"Common Stock","underlying_shares":19208},"source":{"system":"sec-edgar","filing":"0000899243-21-010811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000089924321010811/doc4.xml","form_type":"4"}},{"id":2798937,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-10T02:48:54.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":36086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 5, 2025."}],"balance_after":36086,"derivative":{"exercise_price":65.02,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":36086},"source":{"system":"sec-edgar","filing":"0000899243-21-010811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000089924321010811/doc4.xml","form_type":"4"}},{"id":2932496,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-12-23T23:08:12.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":14767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 17, 2024. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 17, 2024. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":14767,"derivative":{"underlying":"Common Stock","underlying_shares":14767},"source":{"system":"sec-edgar","filing":"0001104659-20-139274","document":"tm2039202-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465920139274/tm2039202-1_4seq1.xml","form_type":"4/A","original_submission_date":"2020-03-19"}},{"id":2932495,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-23T23:08:12.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":48237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 17, 2024."}],"balance_after":48237,"derivative":{"exercise_price":45.14,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":48237},"source":{"system":"sec-edgar","filing":"0001104659-20-139274","document":"tm2039202-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465920139274/tm2039202-1_4seq1.xml","form_type":"4/A","original_submission_date":"2020-03-19"}},{"id":3096312,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-30T12:19:11.000Z","date":"2020-06-29","kind":"purchase","acquired":true,"shares":777,"price":76.64,"value":59549.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"777 shares were purchased by the Reporting Person's IRA."}],"balance_after":41217,"source":{"system":"sec-edgar","filing":"0001104659-20-078440","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465920078440/a4.xml","form_type":"4"}},{"id":3200223,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-20T01:19:55.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":18645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 17, 2024. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 17, 2024. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2015 Omnibus Incentive Compensation Plan (the \"Plan\"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant."}],"balance_after":18645,"derivative":{"underlying":"Common Stock","underlying_shares":18645},"source":{"system":"sec-edgar","filing":"0001179110-20-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000117911020004011/edgar.xml","form_type":"4"}},{"id":3200222,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-20T01:19:55.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":60880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 17, 2024."}],"balance_after":60880,"derivative":{"exercise_price":45.14,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":60880},"source":{"system":"sec-edgar","filing":"0001179110-20-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000117911020004011/edgar.xml","form_type":"4"}},{"id":3393444,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-15T20:43:28.000Z","date":"2019-10-10","kind":"grant","acquired":true,"shares":25813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on October 10, 2023; provided, that the vesting of the option will be accelerated such that 100% of the option will become fully vested upon the achievement of certain clinical, operational, and/or other milestones (approved by the compensation committee) prior to, on, or about December 31, 2019."}],"balance_after":25813,"derivative":{"exercise_price":17.61,"expiration_date":"2029-10-09","underlying":"Common Stock","underlying_shares":25813},"source":{"system":"sec-edgar","filing":"0001179110-19-011012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000117911019011012/edgar.xml","form_type":"4"}},{"id":3404179,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-30T11:16:13.000Z","date":"2019-09-26","kind":"purchase","acquired":true,"shares":2180,"price":24.8,"value":54064.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2,000 shares were purchased by the Reporting Person's Roth IRA and 180 shares were purchased by the Reporting Person's IRA."}],"balance_after":40440,"source":{"system":"sec-edgar","filing":"0001104659-19-051908","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465919051908/a4.xml","form_type":"4"}},{"id":3492284,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-12T11:00:31.000Z","date":"2019-06-11","kind":"purchase","acquired":true,"shares":1920,"price":20.8,"value":39936.0,"ownership":{"direct":true},"balance_after":1920,"source":{"system":"sec-edgar","filing":"0001104659-19-034903","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465919034903/a4.xml","form_type":"4"}},{"id":3582683,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-21T20:07:13.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":75102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 19, 2023."}],"balance_after":75102,"derivative":{"exercise_price":12.95,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":75102},"source":{"system":"sec-edgar","filing":"0001104659-19-016571","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465919016571/a4.xml","form_type":"4"}},{"id":3582682,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-21T11:05:58.000Z","date":"2019-03-19","kind":"purchase","acquired":true,"shares":5340,"price":12.58,"value":67177.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $12.57 to $12.59, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":36340,"source":{"system":"sec-edgar","filing":"0001104659-19-016424","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465919016424/a4.xml","form_type":"4"}},{"id":3582681,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-21T11:05:58.000Z","date":"2019-03-19","kind":"purchase","acquired":true,"shares":60,"price":12.69,"value":761.4,"ownership":{"direct":false,"nature":"By UTMA account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents 60 shares of common stock purchased by the reporting person as custodian for his son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":60,"source":{"system":"sec-edgar","filing":"0001104659-19-016424","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465919016424/a4.xml","form_type":"4"}},{"id":3886840,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-20T21:00:42.000Z","date":"2018-06-19","kind":"purchase","acquired":true,"shares":30600,"price":3.1,"value":94860.0,"ownership":{"direct":true},"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001104659-18-041289","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465918041289/a4.xml","form_type":"4"}},{"id":3886839,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-20T21:00:42.000Z","date":"2018-06-19","kind":"purchase","acquired":true,"shares":400,"price":3.05,"value":1220.0,"ownership":{"direct":true},"balance_after":400,"source":{"system":"sec-edgar","filing":"0001104659-18-041289","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465918041289/a4.xml","form_type":"4"}},{"id":3915026,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-29T21:32:55.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":132000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2015 Omnibus Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 75% in equal increments on a quarterly basis for three years thereafter."}],"balance_after":132000,"derivative":{"exercise_price":3.5,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001104659-18-036457","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000110465918036457/a4.xml","form_type":"4"}}]}